Genmab | Ventes

Name: Genmab | Ventes
Creator: TRADING ECONOMICS
License: https://creativecommons.org/licenses/by/4.0/

width

height

	Sales		Date
Agios Pharmaceuticals AGIO:US	$ 5.58M	4.75M	2022-06
Amarin AMRN:US	$ 94.44M	0.19M	2022-06
Amgen AMGN:US	$ 6594M	356M	2022-06
Artemis Alpha ATS:LN	-9335000	58.77M	2021-06
AstraZeneca AZN:LN	10771M	619M	2022-06
Bayer BAYN:GR	€ 14639M	3521M	2022-03
Biomarin Pharmaceutical BMRN:US	$ 533.8M	14.44M	2022-06
Bluebird Bio BLUE:US	$ 1.52M	0.43M	2022-06
Exelixis EXEL:US	$ 355.98M	95.16M	2022-03
Fresenius Medical Care FME:GR	€ 4757M	208.63M	2022-06
Galapagos GLPG:NA	€ 147.57M	3.54M	2022-06
Genmab GEN:DC	DK 2119M	500M	2022-03
GlaxoSmithKline GSK:LN	6929M	2851M	2022-06
GN Store Nord GN:DC	DK 3859M	241M	2022-03
Hikma Pharmaceutical HIK:LN	1.21B	124M	2022-06
Immunogen IMGN:US	$ 14.16M	23.92M	2022-06
Insmed INSM:US	$ 65.22M	12.11M	2022-06
Lonza Group LONN:SW	2.98B	115M	2022-06
Novartis NOVN:VX	SF 13085M	271M	2022-06
Regeneron Pharmaceuticals REGN:US	$ 2857.2M	107.9M	2022-06
Roche Holding ROG:VX	16.44B	474M	2022-03
Seattle Genetics SGEN:US	$ 497.5M	71.04M	2022-06
William Demant Holding WDH:DC	9.38B	364M	2021-12

Genmab Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2022.